← PUMA BIOTECHNOLOGY, INC.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Total Revenue $958k $27.7m $251.0m $272.3m $225.1m $253.2m $228.0m $235.6m $230.5m $228.4m
Cost of Revenue $207k $5.6m $34.6m $36.8m $39.4m $63.7m $55.1m $62.7m $64.4m $58.2m
Cost of sales $207k $5.6m $34.6m $36.8m $39.4m $63.7m $55.1m $62.7m $64.4m $58.2m
Gross Profit (Calculated) (derived) $751k $22.1m $216.4m $235.4m $185.7m $189.5m $172.9m $173.0m $166.1m $170.2m
Research and development $222.8m $207.8m $164.9m $132.9m $97.7m $71.9m $52.2m $50.4m $54.9m $62.1m
Selling, general and administrative $53.8m $106.7m $146.2m $141.7m $118.5m $116.3m $90.0m $89.9m $80.2m $70.8m
Operating Expenses $276.6m $320.1m $345.7m $311.4m $255.5m $251.9m $204.3m $203.0m $199.5m $191.1m
Total operating costs and expenses $276.6m $320.1m $345.7m $311.4m $255.5m $251.9m $204.3m $203.0m $199.5m $191.1m
Operating Income (Loss) ($276.6m) ($292.4m) ($94.7m) ($39.1m) ($30.4m) $1.3m $23.7m $32.6m $31.0m $37.3m
Additional Financial Items
Amortization of Intangible Assets — $1.6m $3.9m $3.9m $6.3m $8.0m $8.0m $9.7m $9.7m $9.7m
Income (Loss) from Continuing Operations before Income Taxes, Domestic — — — — — — — — $24.1m $35.8m
Interest income $958k $1.3m $1.8m $2.8m $489k $160k $813k $2.6m $4.7m $4.1m
Other income ($373k) ($101k) ($714k) $128k $367k $292k ($28k) $759k $862k $1.0m
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest — — ($113.6m) ($75.5m) ($59.8m) ($28.8m) $457k $22.7m $24.1m $35.8m
Income Before Income Taxes — — ($113.6m) ($75.5m) ($59.8m) ($28.8m) $457k $22.7m $24.1m $35.8m
Net Income (Loss) Attributable to Parent ($276.0m) ($292.0m) ($113.6m) ($75.6m) ($60.0m) ($29.1m) $2k $21.6m $30.3m $31.1m
Net Income (Loss) Available to Common Stockholders, Basic ($276.0m) ($292.0m) ($113.6m) ($75.6m) ($60.0m) ($29.1m) $2k $21.6m $30.3m $31.1m
Earnings Per Share, Basic — — — — — ($29,126.00) $0.00 $0.46 $0.62 $0.62
Earnings Per Share, Diluted ($8.29) ($7.85) ($2.99) ($1.95) ($1.52) ($0.72) $0.00 $0.45 $0.62 $0.61
Weighted Average Number of Shares Outstanding, Basic — — — — 39.6m 40.6m 44.7m 47.1m 48.6m 50.0m
Weighted-average shares of common stock outstanding—basic (in shares) — — — — 39.6m 40.6m 44.7m 47.1m 48.6m 50.0m
Weighted-average shares of common stock outstanding—diluted (in shares) — — — — 39.6m 40.6m 44.9m 47.6m 49.1m 50.7m
Weighted Average Number of Shares Outstanding, Diluted — — — — 39.6m 40.6m 44.9m 47.6m 49.1m 50.7m
Research and Development Expense $222.8m $207.8m $164.9m $132.9m $97.7m $71.9m $52.2m $50.4m $54.9m $62.1m
General and Administrative Expense $53.8m — — — — — — — — —
Selling, General and Administrative Expense $53.8m $106.7m $146.2m $141.7m $118.5m $116.3m $90.0m $89.9m $80.2m $70.8m
Other Nonoperating Income (Expense) ($373k) ($101k) ($714k) $128k $367k $292k ($28k) $759k $862k $1.0m
Costs and Expenses $276.6m $320.1m $345.7m $311.4m $255.5m $251.9m $204.3m $203.0m $199.5m $191.1m
Operating Lease, Expense — — — — — $5.1m $4.9m $4.9m $4.9m $4.5m
Interest Expense (non-operating) — — — — — — — — $12.5m $6.6m
Interest Expense — $720k $11.0m $15.0m $14.0m $12.8m $11.6m $13.3m ($12.5m) ($6.6m)
Current Income Tax Expense (Benefit) — — — — — $324k $455k $1.1m $897k $1.4m
Current income tax (expense) — — — — — — ($455k) ($1.1m) ($897k) ($1.4m)
Deferred income tax (expense) benefit — — — — — — $0 $0 $7.1m ($3.2m)
Total other expenses, net $585k $435k ($18.9m) ($36.5m) ($29.4m) ($30.1m) ($23.3m) ($10.0m) ($6.9m) ($1.5m)
Income Tax Expense (Benefit) $0 $0 $17k $53k $207k $324k $455k $1.1m ($6.2m) $4.7m

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.